Search

Your search keyword '"Calopa, M"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Calopa, M" Remove constraint Author: "Calopa, M"
136 results on '"Calopa, M"'

Search Results

1. Copathology in Progressive Supranuclear Palsy: Does It Matter?

2. MNCD: A New Tool for Classifying Parkinson ' s Disease in Daily Clinical Practice

4. Long-Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings

5. Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project

6. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease

7. Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa

10. Identification of symbol digit modality test score extremes in Huntington's disease

11. alpha-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease

15. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

16. White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease

17. Reduced striato-cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington's disease patients

18. Disentangling apathy subtypes in Huntington's disease: A white matter biomarker of disease profile and progression

19. Awareness of cloud computing in Slovenian and Croatian micro-enterprises

20. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

21. Suicidal ideation in a European Huntington's disease population

22. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

23. Validation of a Portable Device for Mapping Motor and Gait Disturbances in Parkinson’s Disease

24. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry

25. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

26. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

27. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

28. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

29. Validation of a portable device for mapping motor and gait disturbances in Parkinson’s disease

30. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

31. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

32. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

33. NMDA receptor gene variations as modifiers in Huntington disease

34. Weight loss in Huntington disease increases with higher CAG repeat number

36. H03 Awareness Of Dysexecutive Function In Huntington Disease

37. E26 Abnormal Functional Connectivity in Huntington's Disease During a Sequential Motor Task

38. A double-blind, delayed-start trial of rasagiline in Parkinson's disease

39. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease

47. Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile

49. [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis]

50. Transcriptomic differences in MSA clinical variants

Catalog

Books, media, physical & digital resources